Skip to content

PBE

Invesco Biotechnology & Genome ETF

$95.95+0.26 (+0.27%)Close Nov 18, 2026

Adjusted price

+24.80% total return, past year

Key statistics

Expense ratio
0.59%
52-week range
$75.60$104.67
All-time high close
$104.67 on Nov 4, 2026
From all-time high
−8.33%
Max drawdown
−45.69%
Volatility
25.22%
Sharpe ratio
0.48
Beta (5Y monthly)
0.71

Total

1M
−0.14%
YTD
+18.08%
1Y
+24.80%

Per year

3Y
+20.36%
5Y
+6.06%
10Y
+8.68%
20Y
+8.71%
Since 2005
+9.43%

Fund facts

As of Jul 31, 2026
Net assets
$282M
Holdings
33
Top 10 holdings
56.8%
Stocks
100.0%
Cash
17.9%

Sectors

Health Care
100.0%

Top holdings

HoldingWeight (%)
Invesco Private Prime Fund12.9
REGNRegeneron Pharmaceuticals, Inc.5.5
AMGNAmgen Inc.5.2
CDNACareDx, Inc.5.0
VRTXVertex Pharmaceuticals Incorporated5.0
Invesco Private Government Fund5.0
RPRXRoyalty Pharma plc4.9
BIIBBiogen Inc.4.8
GILDGilead Sciences, Inc.4.4
UTHRUnited Therapeutics Corporation4.1